Literature DB >> 27228480

3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.

E Pourbasheer1, R Aalizadeh2.   

Abstract

Three-dimensional quantitative structure-activity relationship (3D-QSAR) modelling was conducted on a series of leucine-rich repeat kinase 2 (LRRK2) antagonists using CoMFA and CoMSIA methods. The data set, which consisted of 37 molecules, was divided into training and test subsets by using a hierarchical clustering method. Both CoMFA and CoMSIA models were derived using a training set on the basis of the common substructure-based alignment. The optimum PLS model built by CoMFA and CoMSIA provided satisfactory statistical results (q(2) = 0.589 and r(2) = 0.927 and q(2) = 0.473 and r(2) = 0.802, respectively). The external predictive ability of the models was evaluated by using seven compounds. Moreover, an external evaluation set with known experimental data was used to evaluate the external predictive ability of the porposed models. The statistical parameters indicated that CoMFA (after region focusing) has high predictive ability in comparison with standard CoMFA and CoMSIA models. Molecular docking was also performed on the most active compound to investigate the existence of interactions between the most active inhibitor and the LRRK2 receptor. Based on the obtained results and CoMFA contour maps, some features were introduced to provide useful insights for designing novel and potent LRRK2 inhibitors.

Entities:  

Keywords:  3D-QSAR; CoMFA; CoMSIA; LRRK2 kinase; molecular docking

Mesh:

Substances:

Year:  2016        PMID: 27228480     DOI: 10.1080/1062936X.2016.1184713

Source DB:  PubMed          Journal:  SAR QSAR Environ Res        ISSN: 1026-776X            Impact factor:   3.000


  2 in total

1.  Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.

Authors:  Kushagra Kashyap; Mohammad Imran Siddiqi
Journal:  Mol Divers       Date:  2021-07-19       Impact factor: 3.364

2.  QSAR Modelling to Identify LRRK2 Inhibitors for Parkinson's Disease.

Authors:  Víctor Sebastián-Pérez; María Jimena Martínez; Carmen Gil; Nuria Eugenia Campillo; Ana Martínez; Ignacio Ponzoni
Journal:  J Integr Bioinform       Date:  2019-02-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.